CONMED CORP (CNMD) Stock Price, Forecast & Analysis
USA - NYSE:CNMD - US2074101013 - Common Stock
CNMD Key Statistics, Chart & Performance
The current stock price of CNMD is 41.63 USD. In the past month the price decreased by -12.87%. In the past year, price decreased by -44.43%.
CNMD Latest News, Press Relases and Analysis
CNMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.06 | 226.31B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.5 | 195.98B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.49 | 150.78B | ||
| SYK | STRYKER CORP | 27.34 | 137.68B | ||
| BDX | BECTON DICKINSON AND CO | 13.24 | 54.74B | ||
| IDXX | IDEXX LABORATORIES INC | 53.05 | 53.52B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.97 | 49.75B | ||
| RMD | RESMED INC | 24.72 | 35.71B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.39 | 32.25B | ||
| PODD | INSULET CORP | 71.78 | 23.09B | ||
| DXCM | DEXCOM INC | 31.45 | 22.94B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.96 | 17.56B |
Related stock screener links
About CNMD
Company Profile
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Company Info
CONMED CORP
11311 Concept Boulevard
Largo FLORIDA 33773 US
CEO: Curt R. Hartman
Employees: 3900
Phone: 17272142974
CONMED CORP / CNMD FAQ
What does CONMED CORP do?
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
What is the stock price of CONMED CORP today?
The current stock price of CNMD is 41.63 USD. The price decreased by -0.98% in the last trading session.
Does CONMED CORP pay dividends?
CONMED CORP (CNMD) has a dividend yield of 1.85%. The yearly dividend amount is currently 0.81.
How is the ChartMill rating for CONMED CORP?
CNMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of CONMED CORP (CNMD)?
The PE ratio for CONMED CORP (CNMD) is 9.21. This is based on the reported non-GAAP earnings per share of 4.52 and the current share price of 41.63 USD.
Can you provide the upcoming dividend date for CONMED CORP?
The next ex-dividend date for CONMED CORP (CNMD) is September 15, 2025.
When does CONMED CORP (CNMD) report earnings?
CONMED CORP (CNMD) will report earnings on 2026-02-03, after the market close.
CNMD Technical Analysis
CNMD Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to CNMD. CNMD scores excellent on profitability, but there are some minor concerns on its financial health.
CNMD Financial Highlights
Over the last trailing twelve months CNMD reported a non-GAAP Earnings per Share(EPS) of 4.52. The EPS increased by 16.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.3% | ||
| ROA | 4.73% | ||
| ROE | 10.97% | ||
| Debt/Equity | 0.88 |
CNMD Forecast & Estimates
12 analysts have analysed CNMD and the average price target is 62.99 USD. This implies a price increase of 51.3% is expected in the next year compared to the current price of 41.63.
For the next year, analysts expect an EPS growth of 9.58% and a revenue growth 5.05% for CNMD